HAIC therapy procedure
HCC
All routine laboratory blood data were obtained within 3 days before HAIC. A femoral arterial puncture was performed in every cycle of treatment. A microcatheter was inserted into the feeding arteries of the HCC. The FOLFOX4 regimen was used via the hepatic artery: leucovorin 400 mg/mHAIC treatment could be combined with targeted therapy and immunotherapy.Targeted therapies included Lenvatinib or Bevacizumab, and immunotherapies included Nivolumab or Atezolizumab.